Maura Greiser

Dr. Maura Greiser

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2002 in Cardiovascular Research
Verified
Journal Article
Closed access
USUlrich Schotten
Ulrich Schotten
MGMaura Greiser
Maura Greiser
DBDirk Benke
Dirk Benke
KBKai Buerkel
Kai Buerkel
BEBritta Ehrenteidt
Britta Ehrenteidt
MAMaurits Allessie
Maurits Allessie
Although AF-induced atrial contractile dysfunction has significant clinical implications the underlying intracellular mechanisms are poorly understood. From the right atrial appendages of 59 consecutive patients undergoing mitral valve surgery (31 in SR, 28 in chronic AF) thin muscle preparations (diameter<0.7 mm) were isolated. Isometric force of contraction was measured in the presence of different concentrations of Ca(2+) and isoprenaline. To assess the function of the sarcoplasmic reticulum, the force-frequency relationship and the post-rest potentiation were studied. The myocardial density of the ryanodine-sensitive calcium release channel (CRC) of the sarcoplasmic reticulum was determined by [3H]ryanodine binding. Myocardial content of SR-Ca(2+)-ATPase (SERCA), phospholamban (Plb), calsequestrin (Cals) and the Na(+)/Ca(2+)-exchanger (NCX) were analyzed by Western blot analysis. Adenylyl cyclase activity was measured with a radiolabeled bioassay using [32P]ATP as a tracer. In 72 muscle preparations of SR patients contractile force was 10.9+/-1.8 mN/mm(2) compared to 3.3+/-0.9 mN/mm(2) (n=48, P<0.01) in AF patients. The positive inotropic effect of isoprenaline was diminished but the stimulatory effect on relaxation and the adenylyl cyclase were not altered in AF patients. The force-frequency relation and the post-rest potentiation were enhanced in atrial myocardium of AF patients. The protein levels of CRC, SERCA, Plb, and Cals were not different between the two groups. In contrast, the Na(+)/Ca(2+)-exchanger was upregulated by 67% in atria of AF patients. AF-induced atrial contractile dysfunction is not due to beta-adrenergic desensitization or dysfunction of the sarcoplasmic reticulum and thus is based on different cellular mechanisms than a ventricular tachycardia-induced cardiomyopathy. Instead, downregulation or altered function of the L-type Ca(2+)-channel and an increased Ca(2+) extrusion via the Na(+)/Ca(2+)-exchanger seem to be responsible for the depressed contractility in remodeled atria.

20 October 2014 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
MGMaura Greiser
Maura Greiser
BKBenoît-Gilles Kerfant
Benoît-Gilles Kerfant
GWGeorge S.B. Williams
George S.B. Williams
NVNiels Voigt
Niels Voigt
EHErik Harks
Erik Harks
USUlrich Schotten
Ulrich Schotten
Atrial fibrillation (AF) is characterized by sustained high atrial activation rates and arrhythmogenic cellular Ca2+ signaling instability; however, it is not clear how a high atrial rate and Ca2+ instability may be related. Here, we characterized subcellular Ca2+ signaling after 5 days of high atrial rates in a rabbit model. While some changes were similar to those in persistent AF, we identified a distinct pattern of stabilized subcellular Ca2+ signaling. Ca2+ sparks, arrhythmogenic Ca2+ waves, sarcoplasmic reticulum (SR) Ca2+ leak, and SR Ca2+ content were largely unaltered. Based on computational analysis, these findings were consistent with a higher Ca2+ leak due to PKA-dependent phosphorylation of SR Ca2+ channels (RyR2s), fewer RyR2s, and smaller RyR2 clusters in the SR. We determined that less Ca2+ release per [Ca2+]i transient, increased Ca2+ buffering strength, shortened action potentials, and reduced L-type Ca2+ current contribute to a stunning reduction of intracellular Na+ concentration following rapid atrial pacing. In both patients with AF and in our rabbit model, this silencing led to failed propagation of the [Ca2+]i signal to the myocyte center. We conclude that sustained high atrial rates alone silence Ca2+ signaling and do not produce Ca2+ signaling instability, consistent with an adaptive molecular and cellular response to atrial tachycardia.

1 October 2010 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
RWReza Wakili
Reza Wakili
YYYung-Hsin Yeh
Yung-Hsin Yeh
XQXiao Yan Qi
Xiao Yan Qi
MGMaura Greiser
Maura Greiser
DCDenis Chartier
Denis Chartier
SNStanley Nattel
Stanley Nattel
Background—: Atrial fibrillation impairs atrial contractility, inducing atrial stunning that promotes thromboembolic stroke. Action potential (AP)-prolonging drugs are reported to normalize atrial hypocontractility caused by atrial tachycardia remodeling (ATR). Here, we addressed the role of AP duration (APD) changes in ATR-induced hypocontractility. Methods and Results—: ATR (7-day tachypacing) decreased APD (perforated patch recording) by ≈50%, atrial contractility (echocardiography, cardiomyocyte video edge detection), and [Ca 2+ ] i transients. ATR AP waveforms suppressed [Ca 2+ ] i transients and cell shortening of control cardiomyocytes; whereas control AP waveforms improved [Ca 2+ ] i transients and cell shortening in ATR cells. However, ATR cardiomyocytes clamped with the same control AP waveform had ≈60% smaller [Ca 2+ ] i transients and cell shortening than control cells. We therefore sought additional mechanisms of contractile impairment. Whole-cell voltage clamp revealed reduced I CaL ; I CaL inhibition superimposed on ATR APs further suppressed [Ca 2+ ] i transients in control cells. Confocal microscopy indicated ATR-impaired propagation of the Ca 2+ release signal to the cell center in association with loss of t-tubular structures. Myofilament function studies in skinned permeabilized cardiomyocytes showed altered Ca 2+ sensitivity and force redevelopment in ATR, possibly due to hypophosphorylation of myosin-binding protein C and myosin light-chain protein 2a (immunoblot). Hypophosphorylation was related to multiple phosphorylation system abnormalities where protein kinase A regulatory subunits were downregulated, whereas autophosphorylation and expression of Ca 2+ -calmodulin-dependent protein kinase IIδ and protein phosphatase 1 activity were enhanced. Recovery of [Ca 2+ ] i transients and cell shortening occurred in parallel after ATR cessation. Conclusions—: Shortening of APD contributes to hypocontractility induced by 1-week ATR but accounts for it only partially. Additional contractility-suppressing mechanisms include I CaL current reduction, impaired subcellular Ca 2+ signal transmission, and altered myofilament function associated with abnormal myosin and myosin-associated protein phosphorylation. The complex mechanistic basis of the atrial hypocontractility associated with AF argues for upstream therapeutic targeting rather than interventions directed toward specific downstream pathophysiological derangements.

1 March 2009 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
MGMaura Greiser
Maura Greiser
HNHans-Ruprecht Neuberger
Hans-Ruprecht Neuberger
EHErik Harks
Erik Harks
AEAli El-Armouche
Ali El-Armouche
PBPeter Boknik
Peter Boknik
USUlrich Schotten
Ulrich Schotten

15 December 2010 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
MGMaura Greiser
Maura Greiser
WLW. Jonathan Lederer
W. Jonathan Lederer
USUlrich Schotten
Ulrich Schotten
Atrial fibrillation (AF) is the most prevalent sustained arrhythmia. As the most important risk factor for embolic stroke, AF is associated with a high morbidity and mortality. Despite decades of research, successful (pharmacological and interventional) ‘ablation’ of the arrhythmia remains challenging. AF is characterized by a diverse aetiology, including heart failure, hypertension, and valvular disease. Based on this understanding, new treatment strategies that are specifically tailored to the underlying pathophysiology of a certain ‘type’ of AF are being developed. One important aspect of AF pathophysiology is altered intracellular Ca2+ handling. Due to the increase in the atrial activation rate and the subsequent initial [Ca2+]i overload, AF induces ‘remodelling’ of intracellular Ca2+ handling. Current research focuses on unravelling the contribution of altered intracellular Ca2+ handling to different types of AF. More specifically, changes in intracellular Ca2+ homeostasis preceding the onset of AF, in conditions which predispose to AF (e.g. heart failure), appear to be different from changes in Ca2+ handling developing after the onset of AF. Here we review and critique altered intracellular Ca2+ handling and its contribution to three specific aspects of AF pathophysiology, (i) excitation–transcription coupling and Ca2+-dependent signalling pathways, (ii) atrial contractile dysfunction, and (iii) arrhythmogenicity.

1 May 2019 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
LBLiron Boyman
Liron Boyman
ACAndrew K. Coleman
Andrew K. Coleman
GZGuiling Zhao
Guiling Zhao
AWAndrew P. Wescott
Andrew P. Wescott
HJHumberto C. Joca
Humberto C. Joca
WLWilliam Jonathan Lederer
William Jonathan Lederer